Latest Post

June 07, 2021

Robust CCI Performance Evaluation Through a New Integrated Approach

Container closure integrity (CCI) has been a fundamental core requirement of containment and delivery solutions in the West product portfolio. Container closure systems (CCSs) must maintain both the sterility and stability of pharmaceutical products; very importantly they must be free of microbial contamination. Microbial ingress into a CCS will jeopardize product sterility.
Qingyu Zeng

Qingyu Zeng, Ph.D.

Fellow and Technical Director

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Introducing Integrated Solutions

    May 15, 2020

    Speed to Market with a Platform Approach

    Fran DeGrazio

    Fran DeGrazio

    Chief Scientific Officer, Scientific Affairs

    Vial Seal Stacked on vial

    February 09, 2018

    Holistic Approach to Container Closure Integrity

    Page McAndrew

    Page McAndrew

    Director, Scientific Communication